Ashish Mandelia - VP, Chief Accounting Officer at Mersana Therapeutics, Inc.

Issuer-level insider activity

Role
VP, Chief Accounting Officer
Issuer ticker
MRSN
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Ashish Mandelia since 21 Sep 2025

Reported holdings for Ashish Mandelia in Mersana Therapeutics, Inc.

Form 4 holding VP, Chief Accounting Officer

Mersana Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$45,168
Report date
06 Jan 2026
Price
$2.71
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding VP, Chief Accounting Officer

Mersana Therapeutics, Inc.

Security class
Restricted Stock Unit
Shares / value
16,667
Estimated value
$9,667
Report date
15 Jan 2025
Price
$0.5800
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Ashish Mandelia in Mersana Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .